Rbin-2

CAS No. 2032282-97-4

Rbin-2( —— )

Catalog No. M34391 CAS No. 2032282-97-4

Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 30 In Stock
5MG 50 In Stock
10MG 88 In Stock
25MG 198 In Stock
50MG 310 In Stock
100MG 453 In Stock
200MG 631 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rbin-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).
  • Description
    Rbin-2 is a potent, reversible and selective inhibitor of Midasin (Mdn1), an enzyme belonging to the AAA+ (ATPases associated with diverse cellular activities) protein family. Rbin-2 inhibits eukaryotic ribosome biogenesis and is a powerfulprobe for the eukaryotic ribosome assembly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2032282-97-4
  • Formula Weight
    335.22
  • Molecular Formula
    C13H11BrN4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 8.33 mg/mL (24.85 mM; Ultrasonic (<60°C)
  • SMILES
    S(CC(C)=C)C=1N=C2C(C=3C(N2)=CC(Br)=CC3)=NN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kawashima SA, et al. Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis. Cell. 2016 Oct 6;167(2):512-524.e14. ?
molnova catalog
related products
  • MB05032

    MB05032 is a potent fructose-,-bisphosphatase inhibitor that inhibits gluconeogenesis and reduces d-lactate-triggered ETosis.

  • Desfesoterodine

    5-hydroxymethyl tolterodine (PNU 200577) is a new muscarinic receptor antagonist with Kb of 0.84 nM.

  • SHP099

    SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.